The role and function of the Regulatory Affairs Committee is to help advance probiotic science with regulators by advocating on behalf of consumers and the probiotics industry, facilitating communication between industry members and regulatory bodies, and representing the industry with regulators on issues of interest/concern. Regulatory Affairs Committee speaks in the name of probiotic industry and is heavily involved in shaping regulations across the globe.
The Regulatory Affairs Committee is the largest of the IPA committees, with a lot of industry representation. Several smaller task forces have been established from this committee to work on initiatives, including ANVISA and the U.S. Taskforce (for FDA).
- Together with members, monitoring regulations related to probiotics in all major jurisdictions
- Drafting important documents and position papers directed to regulatory bodies
- Setting up meetings with regulatory bodies such as FDA, EU Commission, Anvisa, Health Canada, EFSA, Codex etc.
- Cooperate with other organizations in the same field such as IFAC and EFCA in achieving common goals
- Cooperate with IPA Scientific Advisory Board when regulatory issues require scientific insight
- Representing the IPA in all meeting with regulatory bodies
- Suggesting speakers for the IPA World Congress for regulatory related presentations